Company · CIK 0001404281 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Eledon Pharmaceuticals, Inc. · ELDN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 AFForm 4 → | Aug 4, 5:22 pm EDT | David-Alexandre C GrosChief Executive Officer, Director | 549,245 | $3.38 | $658,394 | 168,663 | — | |
| Jul 31, 2026 AFForm 4 → | Aug 4, 5:22 pm EDT | Steven PerrinPresident, Director | 224,491 | $3.38 | $243,826 | 81,215 | — | |
| Sep 11, 2018 PForm 4 → | Sep 13, 8:00 pm EDT | Catherine C. TurkelPresident | 33,680 | $4.78 | $161,147 | 78,199 | +75.7% | plan? |
| Sep 5, 2018 PForm 4 → | Sep 7, 8:00 pm EDT | Catherine C. TurkelPresident | 805 | $3.97 | $3,193 | 805 | — | plan? |
| Mar 13, 2018 AForm 4 → | Mar 15, 6:53 pm EDT | Jon KuwaharaSee Remarks | 11,250 | — | — | 11,250 | — | plan? |
| Mar 13, 2018 AForm 4 → | Mar 15, 6:51 pm EDT | Gregory J. FlesherChief Executive Officer, Director | 30,700 | — | — | 146,556 | — | plan? |
| Mar 13, 2018 AForm 4 → | Mar 15, 6:46 pm EDT | Catherine C. TurkelPresident | 20,000 | — | — | 44,519 | — | plan? |
| May 10, 2017 PForm 4 → | May 11, 8:36 pm EDT | Gregory J. FlesherChief Executive Officer, Director | 58,959 | $9.99 | $589,000 | 115,856 | +104% | plan? |
| May 10, 2017 PForm 4 → | May 11, 8:33 pm EDT | Catherine C. TurkelChief Development Officer | 11,111 | $9.99 | $110,999 | 24,519 | +82.9% | plan? |
| May 10, 2017 PForm 4 → | May 11, 8:30 pm EDT | Christine OcampoSee Remarks | 10,010 | $9.99 | $100,000 | 21,590 | +86.4% | plan? |
| May 9, 2017 AForm 4 → | May 11, 4:13 pm EDT | OrbiMed Israel GP Ltd. +1Director, 10% Owner | 2,537,110 | — | — | 2,537,110 | — | plan? |
| Mar 15, 2016 PForm 4 → | Mar 15, 4:02 pm EDT | Stephen Buckley Jr.Director | 8,000 | $5.74 | $45,920 | 11,000 | +267% | plan? |
| Jan 8, 2016 MForm 4 → | Jan 8, 4:01 pm EST | Jodie Pope MorrisonPresident and CEO, Director | 28,015 | $1.16 | $32,449 | 57,566 | — | plan? |
| Nov 11, 2015 PForm 4 → | Nov 12, 9:06 am EST | Stephen Buckley Jr.Director | 3,000 | $11.25 | $33,750 | 3,000 | — | plan? |
| Sep 21, 2015 SForm 4 → | Sep 22, 4:31 pm EDT | John S. McBrideChief Operating Officer | 13,500 | $14.01 | $189,135 | 0 | −100% | plan? |
| Sep 21, 2015 MForm 4 → | Sep 22, 4:31 pm EDT | John S. McBrideChief Operating Officer | 13,500 | $4.19 | $56,565 | 13,500 | — | plan? |
| Sep 8, 2015 SForm 4 → | Sep 8, 4:23 pm EDT | Lee KalowskiChief Financial Officer | 4,668 | $13.13 | $61,291 | 40,953 | −10.2% | plan? |
| Sep 2, 2015 SForm 4 → | Sep 4, 4:03 pm EDT | Lee KalowskiChief Financial Officer | 2,158 | $12.96 | $27,968 | 45,621 | −4.52% | plan? |
| Jul 28, 2015 SForm 4 → | Jul 30, 5:33 pm EDT | Jodie Pope MorrisonPresident and CEO, Director | 12,564 | $13.70 | $172,127 | 19,551 | −39.1% | plan? |
| Jul 28, 2015 MForm 4 → | Jul 30, 5:33 pm EDT | Jodie Pope MorrisonPresident and CEO, Director | 22,564 | $1.26 | $28,371 | 29,551 | — | plan? |
| Jul 22, 2015 MForm 4 → | Jul 24, 4:23 pm EDT | Jodie Pope MorrisonPresident and CEO, Director | 10,000 | $1.06 | $10,624 | 19,551 | — | plan? |
| Jul 15, 2015 SForm 4 → | Jul 17, 4:05 pm EDT | Novartis Bioventures Ltd +110% Owner | 3,566 | $14.26 | $50,844 | 4,493,458 | −0.08% | plan? |
| Jul 13, 2015 SForm 4 → | Jul 15, 4:18 pm EDT | Novartis Bioventures Ltd +110% Owner | 48,472 | $14.32 | $694,194 | 4,497,024 | −1.07% | plan? |
| Jun 26, 2015 SForm 4 → | Jun 30, 4:48 pm EDT | Jodie Pope MorrisonPresident and CEO, Director | 16,000 | $13.77 | $220,240 | 9,551 | −62.6% | plan? |
| Jun 26, 2015 MForm 4 → | Jun 30, 4:48 pm EDT | Jodie Pope MorrisonPresident and CEO, Director | 16,000 | $1.58 | $25,280 | 17,551 | — | plan? |
| Jun 22, 2015 SForm 4 → | Jun 24, 4:27 pm EDT | John S. McBrideChief Operating Officer | 9,000 | $14.01 | $126,100 | 0 | −100% | plan? |
| Jun 22, 2015 MForm 4 → | Jun 24, 4:27 pm EDT | John S. McBrideChief Operating Officer | 9,000 | $4.19 | $37,710 | 300 | — | plan? |
| Jun 16, 2015 SForm 4 → | Jun 18, 12:54 pm EDT | Novartis Bioventures Ltd +110% Owner | 1,120 | $14.27 | $15,982 | 4,545,496 | −0.02% | plan? |
| Jun 11, 2015 SForm 4 → | Jun 12, 4:05 pm EDT | Novartis Bioventures Ltd +110% Owner | 27,875 | $14.20 | $395,825 | 4,567,312 | −0.61% | plan? |
| Apr 16, 2015 SForm 4 → | Apr 20, 5:08 pm EDT | Lee KalowskiChief Financial Officer | 4,567 | $13.00 | $59,371 | 47,779 | −8.72% | plan? |
| Apr 2, 2015 SForm 4 → | Apr 6, 5:23 pm EDT | Lee KalowskiChief Financial Officer | 2,258 | $11.45 | $25,854 | 52,346 | −4.14% | plan? |
| Mar 18, 2015 SForm 4 → | Mar 20, 2:37 pm EDT | Novartis Bioventures Ltd +110% Owner | 49,141 | $14.50 | $712,545 | 4,595,187 | −1.06% | plan? |
| Jun 15, 2014 SForm 4 → | Jun 16, 2015, 4:17 pm EDT | Novartis Bioventures Ltd +110% Owner | 20,696 | $14.20 | $293,883 | 4,546,616 | −0.45% | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2018 AForm 4 → | Jun 14, 5:54 pm EDT | Cheryl CohenDirector | 9,100 | — | — | 9,100 | — | |
| Jun 13, 2018 AForm 4 → | Jun 14, 5:53 pm EDT | Gary A LyonsDirector | 9,100 | — | — | 9,100 | — | |
| Jun 13, 2018 AForm 4 → | Jun 14, 5:52 pm EDT | Keith KatkinDirector | 9,100 | — | — | 9,100 | — | |
| Jun 13, 2018 AForm 4 → | Jun 14, 5:52 pm EDT | John S. McBrideDirector | 9,100 | — | — | 9,100 | — | |
| Mar 13, 2018 AForm 4 → | Mar 15, 6:53 pm EDT | Jon KuwaharaSee Remarks | 12,000 | — | — | 12,000 | — | |
| Mar 13, 2018 AForm 4 → | Mar 15, 6:51 pm EDT | Gregory J. FlesherChief Executive Officer, Director | 56,500 | — | — | 56,500 | — | |
| Mar 13, 2018 AForm 4 → | Mar 15, 6:46 pm EDT | Catherine C. TurkelPresident | 24,000 | — | — | 24,000 | — | |
| Nov 6, 2017 AForm 4 → | Nov 6, 5:10 pm EST | Catherine C. TurkelPresident | 50,000 | — | — | 50,000 | — | |
| Jul 10, 2017 AForm 4 → | Jul 10, 5:31 pm EDT | Jon KuwaharaSee Remarks | 35,000 | — | — | 35,000 | — | |
| Jun 30, 2017 AForm 4 → | Jul 5, 4:07 pm EDT | Gary A LyonsDirector | 18,000 | — | — | 18,000 | — | |
| Jun 30, 2017 AForm 4 → | Jul 5, 4:07 pm EDT | John S. McBrideDirector | 18,000 | — | — | 18,000 | — | |
| Jun 30, 2017 AForm 4 → | Jul 5, 4:05 pm EDT | Cheryl CohenDirector | 18,000 | — | — | 18,000 | — | |
| Jun 30, 2017 AForm 4 → | Jul 5, 4:05 pm EDT | Jodie Pope MorrisonDirector | 18,000 | — | — | 18,000 | — | |
| Jun 30, 2017 AForm 4 → | Jul 5, 4:05 pm EDT | Keith KatkinDirector | 36,000 | — | — | 36,000 | — | |
| May 24, 2017 AForm 4 → | May 26, 4:06 pm EDT | Gregory J. FlesherChief Executive Officer, Director | 250,000 | — | — | 250,000 | — | |
| May 24, 2017 AForm 4 → | May 26, 4:06 pm EDT | Catherine C. TurkelChief Development Officer | 52,500 | — | — | 52,500 | — | |
| May 24, 2017 AForm 4 → | May 26, 4:05 pm EDT | Christine OcampoSee Remarks | 52,500 | — | — | 52,500 | — | |
| Jun 16, 2016 AForm 4 → | Jun 16, 4:02 pm EDT | Cheryl CohenDirector | 12,000 | — | — | 12,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 16, 4:03 pm EDT | Joseph A., Yanchik IIIDirector | 12,000 | — | — | 12,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 16, 4:02 pm EDT | David A. KesslerDirector | 12,000 | — | — | 12,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 16, 4:02 pm EDT | Stephen Buckley Jr.Director | 12,000 | — | — | 12,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 16, 4:02 pm EDT | Timothy J BarberichDirector | 12,000 | — | — | 12,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 16, 4:02 pm EDT | Seth Loring HarrisonDirector, 10% Owner | 12,000 | — | — | 12,000 | — | |
| Jan 8, 2016 MForm 4 → | Jan 8, 4:01 pm EST | Jodie Pope MorrisonPresident and CEO, Director | 28,015 | — | — | 37,878 | — | |
| Dec 15, 2015 AForm 4 → | Dec 17, 4:22 pm EST | Karen Jean FerranteHead Res. & Dev. & Chief Med. | 62,000 | — | — | 62,000 | — | |
| Dec 15, 2015 AForm 4 → | Dec 17, 4:02 pm EST | Jodie Pope MorrisonPresident and CEO, Director | 189,000 | — | — | 189,000 | — | |
| Dec 15, 2015 AForm 4 → | Dec 17, 4:01 pm EST | Lee KalowskiChief Financial Officer | 62,000 | — | — | 62,000 | — | |
| Dec 15, 2015 AForm 4 → | Dec 17, 4:01 pm EST | Gerald E QuirkGeneral Counsel, Executive VP | 62,000 | — | — | 62,000 | — | |
| Dec 15, 2015 AForm 4 → | Dec 17, 4:01 pm EST | John S. McBrideChief Operating Officer | 62,000 | — | — | 62,000 | — | |
| Sep 21, 2015 MForm 4 → | Sep 22, 4:31 pm EDT | John S. McBrideChief Operating Officer | 13,500 | — | — | 186,678 | — | |
| Jul 28, 2015 MForm 4 → | Jul 30, 5:33 pm EDT | Jodie Pope MorrisonPresident and CEO, Director | 22,564 | — | — | 57,878 | — | |
| Jul 22, 2015 MForm 4 → | Jul 24, 4:23 pm EDT | Jodie Pope MorrisonPresident and CEO, Director | 10,000 | — | — | 15,015 | — | |
| Jun 26, 2015 MForm 4 → | Jun 30, 4:48 pm EDT | Jodie Pope MorrisonPresident and CEO, Director | 16,000 | — | — | 325,300 | — | |
| Jun 22, 2015 MForm 4 → | Jun 24, 4:27 pm EDT | John S. McBrideChief Operating Officer | 9,000 | — | — | 200,178 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 1:41 pm EDT | Stephen Buckley Jr.Director | 12,000 | — | — | 12,000 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 11:09 am EDT | Joseph A., Yanchik IIIDirector | 12,000 | — | — | 12,000 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 11:09 am EDT | David A. KesslerDirector | 12,000 | — | — | 12,000 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 11:09 am EDT | Seth Loring HarrisonDirector, 10% Owner | 12,000 | — | — | 12,000 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 11:07 am EDT | Timothy J BarberichDirector | 12,000 | — | — | 12,000 | — | |
| May 26, 2015 AForm 4 → | May 28, 6:10 pm EDT | Gerald E QuirkGeneral Counsel, Executive VP | 214,605 | — | — | 214,605 | — | |
| Apr 9, 2015 AForm 4 → | Apr 13, 5:13 pm EDT | Cheryl CohenDirector | 25,000 | — | — | 25,000 | — | |
| Jan 8, 2015 AForm 4 → | Jan 12, 4:48 pm EST | Stephen Buckley Jr.Director | 25,000 | — | — | 25,000 | — |